Open AccessImpact of the COVID-19 Pandemic on Type 2 Diabetes Care Delivery
Author(s) -
Stephanie Ann Hooker,
Anjali R. Truitt,
Jeffrey Anderson,
Sheryl Kane,
Patrick J. O’Connor,
JoAnn M. SperlHillen
Publication year - 2022
Publication title -
clinical diabetes
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.931
H-Index - 37
eISSN - 1945-4953
pISSN - 0891-8929
DOI - 10.2337/cd21-0116
Subject(s) - telehealth , medicine , pandemic , medicaid , covid-19 , type 2 diabetes , family medicine , diabetes mellitus , health care , ethnic group , telemedicine , disease , virology , infectious disease (medical specialty) , endocrinology , sociology , outbreak , anthropology , economics , economic growth
The COVID-19 pandemic instigated major changes in care delivery, but our understanding of how the rapid transition from in-person to telehealth encounters affected the care of patients with chronic conditions such as type 2 diabetes remains incomplete. This study examined changes in primary care encounters, A1C testing rates, and the likelihood of meeting A1C guidelines before and during the first 9 months of the coronavirus disease 2019 pandemic in a large health care system. It found significant decreases in utilization and testing rates and the likelihood of meeting A1C guidelines, primarily driven by missing A1C tests. Patients who had all telehealth encounters or no encounters, who identified as racial or ethnic minorities, or had Medicaid or no insurance were significantly more likely to miss A1C tests.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom